Practice Areas:
Intellectual property
Jurisdictions:
Biography
For 20 years, Jennifer has been pivotal in bet-the-company jury trials, before the International Trade Commission, and on appeal to the Federal Circuit and Supreme Court. She litigates patents across a range of technical areas, with emphasis on pharmaceuticals and biotechnology, and experience in GPS devices, geospatial mapping, and medical devices.
Jennifer is ranked in the IAM Patent 1000, Lawdragon 500 Leading Litigators in America and Global IP Lawyers, Chambers USA, and The Legal 500, and named among Managing IP's IP Stars and Top 250 Women in IP in 2024, 2025, and 2026.
Benchmark Litigation has recognized her among its Top 250 Women in Litigation since 2024 and as a Litigation Star since 2025. In 2026, she received NYU Law's Distinguished Alumni Achievement Award. Earlier honors include the New York Law Journal's Distinguished Leader and Rising Star awards, NAPABA's Best Under 40 award, and Chambers USA's Up and Coming designation.
Jennifer is the immediate past FCBA President and former co-chair of its Patent Litigation, Mock Argument, and Rules Committees, earning the Hutchinson Committee Award twice. She serves on the NYU Law Board of Trustees and its Alumni of Color Association Advisory Committee and is an American Bar Foundation Fellow.
Jennifer maintains an active pro bono practice combatting anti-Asian violence, co-authoring AABANY's two reports on the subject and representing the families of nearly every person killed in anti-Asian attacks in New York City over the past four years. In 2023, she testified before the U.S. Commission on Civil Rights at its first hearing on anti-Asian racism in 30 years, earning NAPABA's Pro Bono Service Award and Corporate Counsel's Ally of the Year Award.
Jennifer holds an A.B. in Biochemical Sciences from Harvard, clerked for Judge Alan D. Lourie of the Federal Circuit, and serves as FCBA President and Advisory Council member.
Jennifer is ranked in the IAM Patent 1000, Lawdragon 500 Leading Litigators in America and Global IP Lawyers, Chambers USA, and The Legal 500, and named among Managing IP's IP Stars and Top 250 Women in IP in 2024, 2025, and 2026.
Benchmark Litigation has recognized her among its Top 250 Women in Litigation since 2024 and as a Litigation Star since 2025. In 2026, she received NYU Law's Distinguished Alumni Achievement Award. Earlier honors include the New York Law Journal's Distinguished Leader and Rising Star awards, NAPABA's Best Under 40 award, and Chambers USA's Up and Coming designation.
Jennifer is the immediate past FCBA President and former co-chair of its Patent Litigation, Mock Argument, and Rules Committees, earning the Hutchinson Committee Award twice. She serves on the NYU Law Board of Trustees and its Alumni of Color Association Advisory Committee and is an American Bar Foundation Fellow.
Jennifer maintains an active pro bono practice combatting anti-Asian violence, co-authoring AABANY's two reports on the subject and representing the families of nearly every person killed in anti-Asian attacks in New York City over the past four years. In 2023, she testified before the U.S. Commission on Civil Rights at its first hearing on anti-Asian racism in 30 years, earning NAPABA's Pro Bono Service Award and Corporate Counsel's Ally of the Year Award.
Jennifer holds an A.B. in Biochemical Sciences from Harvard, clerked for Judge Alan D. Lourie of the Federal Circuit, and serves as FCBA President and Advisory Council member.
Recent matter/case highlights
- Amicus Therapeutics
Co-lead counsel (with Nick Groombridge) in a Hatch-Waxman matter against Teva, Aurobindo, and Lupin involving abbreviated new drug applications seeking approval to market generic versions of Galafold (migalastat), an orphan drug used to treat Fabry disease.
- Nearmap
Co-lead counsel (with Nick Groombridge) for defendant Nearmap in a 13-patent litigation in the District of Utah involving geospatial mapping technology, trade secret misappropriation claims, and a patent misuse defense.
- 10x Genomics and Stanford University
Co-lead counsel (with Nick Groombridge) for plaintiffs 10x Genomics and Stanford University in litigation asserting six patents covering core single-cell sequencing technology.
Key practice areas
- Intellectual property
Sector expertise
- Pharmaceutical and life sciences
Academic qualifications
- J.D., New York University School of Law
- A.B., Biochemical Sciences, Harvard University
Association memberships
- Federal Circuit Bar Association (FCBA)
- NYU School of Law Board of Trustees
- Advisory Committee of the NYU School of Law Alumni of Color Association
- Fellow of the American Bar Foundation
- Asian American Bar Association of New York (AABANY)
- USA for UNFPA
Bar Admissions
- New York
- New Jersey
- Supreme Court of the United States
- U.S. Court of Appeals for the Federal Circuit
- U.S. Court of Appeals for the Second Circuit
- U.S. District Court for the Eastern District of New York
- U.S. District Court for the Southern District of New York
- U.S. Patent and Trademark Office
Address:
Tel:+1332.269.0032
Email:Contact this practitioner
Website:https://www.groombridgewu.com
565 Fifth Avenue, Suite 2900
New York, New York, 10017
United States